sotorasib has been researched along with Inflammation* in 1 studies
1 trial(s) available for sotorasib and Inflammation
| Article | Year |
|---|---|
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
KRAS is the most frequently mutated oncogene in cancer and encodes a key signalling protein in tumours Topics: Animals; Antineoplastic Agents; Cell Proliferation; Drug Synergism; Humans; Immunotherapy; Inflammation; Lung Neoplasms; Mice; Phosphorylation; Piperazines; Proto-Oncogene Proteins p21(ras); Pyridines; Pyrimidines; Signal Transduction; Treatment Outcome; Tumor Microenvironment | 2019 |